Exact Mass: 388.2460906

Exact Mass Matches: 388.2460906

Found 75 metabolites which its exact mass value is equals to given mass value 388.2460906, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5,6-Dihydroxyprostaglandin F1a

7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-5,6-dihydroxyheptanoic acid

C20H36O7 (388.2460906)


Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways. [HMDB] Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.

   

ent-2-benzylidenebeyer-15-en-3,12-dione

ent-2-benzylidenebeyer-15-en-3,12-dione

C27H32O2 (388.24021719999996)


   

Norcaperatic acid

Norcaperatic acid

C20H36O7 (388.2460906)


   
   
   

Palmitoleoyl 3-carbacyclic Phosphatidic Acid

Palmitoleoyl 3-carbacyclic Phosphatidic Acid

C20H37O5P (388.23784820000003)


   

Gly Gly Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]hexanoic acid

C16H32N6O5 (388.24340620000004)


   

Gly Lys Gly Lys

(2S)-6-amino-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}hexanoic acid

C16H32N6O5 (388.24340620000004)


   

Gly Lys Lys Gly

2-[(2S)-6-amino-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]hexanamido]acetic acid

C16H32N6O5 (388.24340620000004)


   

Lys Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)hexanoic acid

C16H32N6O5 (388.24340620000004)


   

Lys Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}hexanamido]acetic acid

C16H32N6O5 (388.24340620000004)


   

Lys Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]acetamido}acetic acid

C16H32N6O5 (388.24340620000004)


   
   

3-[4-(N-Boc)piperazin-1-yl]phenylboronic acid pinacol ester

3-[4-(N-Boc)piperazin-1-yl]phenylboronic acid pinacol ester

C21H33BN2O4 (388.25332480000003)


   
   

1,2-bis(ethenyl)benzene,buta-1,3-diene,methyl 2-methylprop-2-enoate,styrene

1,2-bis(ethenyl)benzene,buta-1,3-diene,methyl 2-methylprop-2-enoate,styrene

C27H32O2 (388.24021719999996)


   
   

Galeterone

Galeterone

C26H32N2O (388.25145019999997)


D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

8,8-bis(1H-indol-3-yl)-2,6-dimethyl-2-octanol

8,8-bis(1H-indol-3-yl)-2,6-dimethyl-2-octanol

C26H32N2O (388.25145019999997)


   

4-(4-Boc-piperazino)phenylboronic Acid Pinacol Ester

4-(4-Boc-piperazino)phenylboronic Acid Pinacol Ester

C21H33BN2O4 (388.25332480000003)


   

2-[4-(N-Boc)piperazin-1-yl]phenylboronic acid pinacol ester

2-[4-(N-Boc)piperazin-1-yl]phenylboronic acid pinacol ester

C21H33BN2O4 (388.25332480000003)


   

2,8-Diazaspiro[4.5]decane-2,8-dicarboxylic acid, 2-(1,1-dimethylethyl) 8-(phenylmethyl) ester

2,8-Diazaspiro[4.5]decane-2,8-dicarboxylic acid, 2-(1,1-dimethylethyl) 8-(phenylmethyl) ester

C22H32N2O4 (388.2361952)


   
   

(2S)-6-amino-2-[[(2S)-4-amino-2-[[(2S)-2,6-diaminohexanoyl]amino]-4-oxobutanoyl]amino]hexanoic acid

(2S)-6-amino-2-[[(2S)-4-amino-2-[[(2S)-2,6-diaminohexanoyl]amino]-4-oxobutanoyl]amino]hexanoic acid

C16H32N6O5 (388.24340620000004)


   

N-oleoyltaurine(1-)

N-oleoyltaurine(1-)

C20H38NO4S- (388.25214080000006)


A fatty acid-taurine conjugate obtained by deprotonation of the sulfonate group of N-oleoyltaurine; major species at pH 7.3.

   

(13R)-13-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid

(13R)-13-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid

C20H36O7 (388.2460906)


   

14-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid

14-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid

C20H36O7 (388.2460906)


   

2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclohexylacetamide

2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclohexylacetamide

C22H32N2O4 (388.2361952)


   

(1R,9S,10S,11S)-12-(cyclopropylmethyl)-N-[3-(dimethylamino)propyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-12-(cyclopropylmethyl)-N-[3-(dimethylamino)propyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C21H32N4O3 (388.24742819999994)


   

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide

C22H32N2O4 (388.2361952)


   

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide

C22H32N2O4 (388.2361952)


   

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide

C22H32N2O4 (388.2361952)


   

N-[[(2S,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide

N-[[(2S,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide

C22H32N2O4 (388.2361952)


   

(1S,9R,10R,11R)-12-(cyclopropylmethyl)-N-[3-(dimethylamino)propyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-12-(cyclopropylmethyl)-N-[3-(dimethylamino)propyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C21H32N4O3 (388.24742819999994)


   
   
   

(E,E)-(1R,2S,5R)-8-Phenylmenthyl 5-phenyl-2,4-pentadienoate

(E,E)-(1R,2S,5R)-8-Phenylmenthyl 5-phenyl-2,4-pentadienoate

C27H32O2 (388.24021719999996)


   

5,6-Dihydroxyprostaglandin F1a

5,6-Dihydroxyprostaglandin F1a

C20H36O7 (388.2460906)